Cure My Disease

Don't miss your cure!

 Log in / Sign up

Oral hemophilia treatment enters human testing

NCT ID NCT07220564

Recruiting now Disease control Sponsor: Novo Nordisk A/S Source: ClinicalTrials.gov ↗

Summary

This early study is testing a new oral medicine called Inno8 in people with Hemophilia A to see if it's safe and how the body processes it. About 30 adult men with Hemophilia A will take different doses of the medicine over 11 weeks. Researchers will monitor for side effects and measure how the medicine affects blood clotting markers.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HAEMOPHILIA A are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • AKH - Klin. Abt. f. Haematologie u. Haemostaseologie

    RECRUITING

    Vienna, 1090, Austria

  • AOU Careggi Firenze

    RECRUITING

    Florence, 50134, Italy

  • Azienda Ospedaliera Universitaria Federico II di Napoli

    RECRUITING

    Naples, 80131, Italy

  • Hospital Clinico Universitario de Salamanca

    RECRUITING

    Salamanca, 37007, Spain

  • Hospital Regional Universitario de Málaga

    RECRUITING

    Málaga, 29010, Spain

  • Hospital Universitario La Paz

    RECRUITING

    Madrid, 28046, Spain

  • Hospital Vall d'Hebron

    RECRUITING

    Barcelona, 08035, Spain

  • Indiana Hemophilia-Thromb Ctr

    RECRUITING

    Indianapolis, Indiana, 46260, United States

  • Instytut Hematologii i Transfuzjologii

    RECRUITING

    Warsaw, 02-776, Poland

  • Medizinische Hochschule Hannover - Hämatologie, Hämostaseologie, Onkologie

    RECRUITING

    Hanover, 30625, Germany

  • Penn State MS Hershey Med Ctr

    RECRUITING

    Hershey, Pennsylvania, 17033-2360, United States

  • Queen Elizabeth Hospital, Birmingham - Haemophilia

    NOT_YET_RECRUITING

    Birmingham, B15 2TH, United Kingdom

  • Royal Free Hospital - Haemophilia

    RECRUITING

    London, NW3 2QG, United Kingdom

  • Royal Hallamshire Hospital

    NOT_YET_RECRUITING

    Sheffield, S10 2JF, United Kingdom

  • St Christopher Hosp for Child

    NOT_YET_RECRUITING

    Philadelphia, Pennsylvania, 19134, United States

  • UC Denver Hemoph & Thrombo Ctr

    NOT_YET_RECRUITING

    Aurora, Colorado, 80045, United States

  • University of Iowa_Iowa City

    RECRUITING

    Iowa City, Iowa, 52242, United States

  • Universitätsklinik für Innere Medizin V

    RECRUITING

    Innsbruck, 6020, Austria

  • Universitätsklinikum Bonn - Institut für Experimentelle Hämatologie

    NOT_YET_RECRUITING

    Bonn, 53127, Germany

  • Uniwersytecki Szpital Kliniczny w Bialymstoku

    RECRUITING

    Bialystok, 15-276, Poland

  • Uniwersyteckie Centrum Kliniczne

    RECRUITING

    Gdansk, 80-214, Poland

  • Vivantes Netzwerk für Gesundheit GmbH - Vivantes Klinikum im Friedrichshain

    RECRUITING

    Berlin, 10249, Germany

Conditions

Explore the condition pages connected to this study.

HAEMOPHILIA A